PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges.

PHILADELPHIA, PA — PCI Pharma Services has finalized the acquisition of Ajinomoto Althea, Inc. (Althea), a U.S.-based sterile fill-finish contract development and manufacturing organization ...

A pharma business has announced a new three-year charity partnership with Hospice of the Valleys, which provides ...

(BUSINESS WIRE )-- PCI Pharma Services , (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma's most complex therapies, is investing more ...

PCI Pharma Services plans to grow its largest manufacturing facility by more than 50%, pouring about $146 million into a 545,000-square-foot expansion of its Rockford facility.

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in ...